(Q49144579)

18 February 2018

reason for preferred rank

title

Functional evidence for subsensitivity of noradrenergic α2 receptors after chronic desipramine treatment (English)

1 reference

https://api.crossref.org/works/10.1016/0024-3205(80)90431-2

9 September 2023

Functional evidence for subsensitivity of noradrenergic alpha 2 receptors after chronic desipramine treatment (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6257997

9 September 2023

author name string

C. Spyraki

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6257997

9 September 2023

H. C. Fibiger

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6257997

9 September 2023

language of work or name

English

0 references

publication date

1 November 1980

1 reference

18 February 2018

17 November 1980

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=6257997

full work available at URL

9 September 2023

https://api.elsevier.com/content/article/PII:0024320580904312?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0024-3205(80)90431-2

https://api.elsevier.com/content/article/PII:0024320580904312?httpAccept=text/plain

9 September 2023

1 reference

https://api.crossref.org/works/10.1016/0024-3205(80)90431-2

9 September 2023

1 reference

18 February 2018

volume

27

1 reference

18 February 2018

issue

20

1 reference

18 February 2018

page(s)

1863-1867

1 reference

18 February 2018

Inhibition of both noradrenergic and serotonergic neurons in brain by the α-adrenergic agonist clonidine

cites work

1

1 reference

https://api.crossref.org/works/10.1016/0024-3205(80)90431-2

Evidence for a central noradrenaline receptor stimulation by clonidine.

9 September 2023

2

1 reference

https://api.crossref.org/works/10.1016/0024-3205(80)90431-2

Effects of phenoxybenzamine, aceperone and clonidine on the level of 3-methoxy-4-hydroxyphenylglycol (MOPEG) in rat brain

9 September 2023

4

1 reference

https://api.crossref.org/works/10.1016/0024-3205(80)90431-2

Advances in biochemical psychopharmacology

9 September 2023

6

16

433

Aghajanian

1977

1 reference

https://api.crossref.org/works/10.1016/0024-3205(80)90431-2

Presynaptic regulation of catecholamine release

9 September 2023

7

1 reference

https://api.crossref.org/works/10.1016/0024-3205(80)90431-2

Regulation of noradrenaline release by presynaptic receptor systems

9 September 2023

8

1 reference

https://api.crossref.org/works/10.1016/0024-3205(80)90431-2

Different alpha-adrenoreceptors in the central nervous system mediating biochemical and functional effects of clonidine and receptor blocking agents

9 September 2023

9

1 reference

https://api.crossref.org/works/10.1016/0024-3205(80)90431-2

Behavioural and biochemical effects of 2-(2,6-dichlorophenylamino)-2-imidazoline hydrochloride (St 155) on the central nervous system

9 September 2023

10

1 reference

https://api.crossref.org/works/10.1016/0024-3205(80)90431-2

Adrenergic receptor blocking agents: effects on central noradrenaline and dopamine receptors and on motor activity

9 September 2023

11

1 reference

https://api.crossref.org/works/10.1016/0024-3205(80)90431-2

Effects of low doses of catecholamine receptor agonists on exploration in mice

9 September 2023

12

1 reference

https://api.crossref.org/works/10.1016/0024-3205(80)90431-2

Qualitative aspects on motility changes in mice induced by low doses of apomorphine and clonidine

9 September 2023

13

1 reference

https://api.crossref.org/works/10.1016/0024-3205(80)90431-2

Depression of exploratory activity by clonidine in rats as a model for the detection of relative pre- and postsynaptic central noradrenergic receptor selectivity of ?-adrenolytic drugs

9 September 2023

14

1 reference

https://api.crossref.org/works/10.1016/0024-3205(80)90431-2

Evidence for two distinct types of postsynaptic alpha-adrenoceptor in vascular smooth muscle in vivo

9 September 2023

15

1 reference

https://api.crossref.org/works/10.1016/0024-3205(80)90431-2

Clonidine: attenuation of sedative action by facilitated central noradrenergic neurotransmission

9 September 2023

16

1 reference

https://api.crossref.org/works/10.1016/0024-3205(80)90431-2

Interaction of antidepressants with clonidine on rat brain total 3-methoxy-4-hydroxyphenylglycol

9 September 2023

17

1 reference

https://api.crossref.org/works/10.1016/0024-3205(80)90431-2

Effects of chronic desipramine treatment on rat brain noradrenergic responses to α-adrenergic drugs

9 September 2023

18

1 reference

https://api.crossref.org/works/10.1016/0024-3205(80)90431-2

Feedback Inhibition of Brain Noradrenaline Neurons by Tricyclic Antidepressants: α-Receptor Mediation

9 September 2023

19

1 reference

https://api.crossref.org/works/10.1016/0024-3205(80)90431-2

Strychnine and suppression of exploration.

9 September 2023

20

1 reference

https://api.crossref.org/works/10.1016/0024-3205(80)90431-2

Tricyclic antidepressants: Effects on the firing rate of brain noradrenergic neurons

9 September 2023

21

1 reference

https://api.crossref.org/works/10.1016/0024-3205(80)90431-2

Catecholamine receptors on locus coeruleus neurons: Pharmacological characterization

9 September 2023

22

1 reference

https://api.crossref.org/works/10.1016/0024-3205(80)90431-2

Presynaptic Alpha-Receptor Subsensitivity After Long-Term Antidepressant Treatment

9 September 2023

23

1 reference

https://api.crossref.org/works/10.1016/0024-3205(80)90431-2

Altered exploratory behaviour after 6-OHDA lesion to the dorsal noradrenergic bundle

9 September 2023

24

1 reference

https://api.crossref.org/works/10.1016/0024-3205(80)90431-2

Ascending catecholamine pathways and amphetamine-induced locomotor activity: Importance of dopamine and apparent non-involvement of norepinephrine

9 September 2023

25

1 reference

https://api.crossref.org/works/10.1016/0024-3205(80)90431-2

Behavioural effects of 6-hydroxydopamine-induced depletion of spinal noradrenaline

9 September 2023

26

1 reference

https://api.crossref.org/works/10.1016/0024-3205(80)90431-2

Development of β-adrenergic receptor subsensitivity by antidepressants

9 September 2023

27

1 reference

https://api.crossref.org/works/10.1016/0024-3205(80)90431-2

Journal of Pharmacology and Experimental Therapeutics

9 September 2023

28

209

256

Bergstrom

1979

1 reference

https://api.crossref.org/works/10.1016/0024-3205(80)90431-2

Differential effects of antidepressant treatment on brain monoaminergic receptors

9 September 2023

29

1 reference

https://api.crossref.org/works/10.1016/0024-3205(80)90431-2

On the mechanism of action of the antidepressant drugs amitriptyline and nortriptyline. Evidence for 5-hydroxytryptamine receptor blocking activity

9 September 2023

31

1 reference

https://api.crossref.org/works/10.1016/0024-3205(80)90431-2

Modifications of central 5-hydroxytryptamine binding sites in synaptic membranes from rat brain after long-term administration of tricyclic antidepressants

9 September 2023

32

1 reference

https://api.crossref.org/works/10.1016/0024-3205(80)90431-2

Chronic treatment with antidepressants prevents the inhibitory effect of small doses of apomorphine on dopamine synthesis and motor activity

9 September 2023

33

1 reference

https://api.crossref.org/works/10.1016/0024-3205(80)90431-2

9 September 2023

Identifiers

1 reference

18 February 2018

1 reference

18 February 2018